Welcome to the largest gathering for mRNA professionals
With over 800 mRNA drugs now in development and the industry accelerating towards clinical success, the mRNA-Based Therapeutics Summit returns for its 3rd year as the industry’s largest networking opportunity to date, showcasing exclusive new data from the movers and shakers in the field.
Ensure your whole team stays ahead of the curve by joining 300+ key mRNA opinion leaders from Moderna, BioNTech, Sanofi including regulatory insights from the FDA and EMA at the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.
Expect 100+ world-class speakers from large pharma, innovative biotechs, and academia, with 3 days of jam-packed content with 5 dedicated tracks (discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics) deep-dive focus and workshop days, C-Level Fireside Discussions and more, enabling you to overcome industry hurdles including optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!
Among Our World-Class Speaker Faculty
Vice President - Clinical Development
Executive Director & Program Lead – RSV Vaccines
Director - Center For Biologics Evaluation & Research
US Food & Drug Administration (FDA)
Kernal Biologics Inc.
Global Head of Regulatory PT Cell & Gene Therapies
Chief Technology Officer & Global Head of Research, mRNA Center of Excellence
The Biggest Meeting in the mRNA Calendar
Hours of Dedicated In-Person Networking
Tracks of Content
Pre-Conference Workshop Day
Interactive Panel Discussions